Načítá se...
Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes
OBJECTIVE: As gene-based therapies may soon arise for patients with spinocerebellar ataxia (SCA), there is a critical need to identify biomarkers of disease progression with effect sizes greater than clinical scores, enabling trials with smaller sample sizes. METHODS: We enrolled a unique cohort of...
Uloženo v:
| Vydáno v: | Neuroimage Clin |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6005808/ https://ncbi.nlm.nih.gov/pubmed/29922574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2018.06.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|